APC and malignant colon neoplasm: Two other small molecules, IWR-3 and XAV939, are recently shown to stimulate the degradation of β-catenin by stabilizing axin and thereby inhibiting the proliferation of DLD-1 colon cancer cells, which carry a mutation in APC [29], [30].